Activity reports highlight contributions to SCOAP3 Phase 3 and feedback from seminars in Japan, indicating engagement outcomes.
■SPARC Japan Activity Reports SPARC Japan Governing Board[p.1] Contributions allocated for SCOAP3 Phase 3 (2020–2022)[p.1] ■SPARC Japan Seminar Report Outline[p.3] Presentation Abstracts and Speakers[p.4] Panel Discussion[p.5] Attendee Feedback[p.6] Afterword[p.6]
No takes yet. Share an insight, caveat, or question.
A 2020 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: